Trial Profile
An Open-Label, Two-Period, Sequential Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of Desvenlafaxine Succinate Sustained Release (DVS SR) On The Pharmacokinetics Of Midazolam When Coadministered In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2011
Price :
$35
*
At a glance
- Drugs Desvenlafaxine (Primary) ; Midazolam
- Indications Anxiety disorders; Depressive disorders
- Focus Pharmacokinetics
- Sponsors Wyeth
- 23 Aug 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2010 Planned initiation date changed from 1 Aug 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 08 Jun 2010 Planned end date changed from 1 Oct 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.